These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3042187)

  • 21. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
    Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD
    J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of complement in the therapeutic activity of rituximab in a murine B lymphoma model homing in lymph nodes.
    Golay J; Cittera E; Di Gaetano N; Manganini M; Mosca M; Nebuloni M; van Rooijen N; Vago L; Introna M
    Haematologica; 2006 Feb; 91(2):176-83. PubMed ID: 16461301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects.
    Carrillo-Vico A; Lardone PJ; Naji L; Fernández-Santos JM; Martín-Lacave I; Guerrero JM; Calvo JR
    J Pineal Res; 2005 Nov; 39(4):400-8. PubMed ID: 16207296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-glucan attenuates inflammatory cytokine release and prevents acute lung injury in an experimental model of sepsis.
    Bedirli A; Kerem M; Pasaoglu H; Akyurek N; Tezcaner T; Elbeg S; Memis L; Sakrak O
    Shock; 2007 Apr; 27(4):397-401. PubMed ID: 17414422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant bovine soluble CD14 reduces severity of experimental Escherichia coli mastitis in mice.
    Lee JW; Paape MJ; Zhao X
    Vet Res; 2003; 34(3):307-16. PubMed ID: 12791240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.
    Cheung NK; Modak S
    Clin Cancer Res; 2002 May; 8(5):1217-23. PubMed ID: 12006541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of multiple injections of beta-glucan on non-specific immune response and disease resistance in Labeo rohita fingerlings.
    Misra CK; Das BK; Mukherjee SC; Pattnaik P
    Fish Shellfish Immunol; 2006 Mar; 20(3):305-19. PubMed ID: 16039142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucan effect on the survival of mice after radiation exposure.
    Petruczenko A
    Acta Physiol Pol; 1984; 35(3):231-6. PubMed ID: 6537716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of soluble and particulate glucans on survival in irradiated mice.
    Patchen ML; MacVittie TJ
    J Biol Response Mod; 1986 Feb; 5(1):45-60. PubMed ID: 3958754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of interleukin-6 synthesis in an animal model of septic shock by anti-C5a monoclonal antibodies.
    Höpken U; Mohr M; Strüber A; Montz H; Burchardi H; Götze O; Oppermann M
    Eur J Immunol; 1996 May; 26(5):1103-9. PubMed ID: 8647174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement-dependent immune complex-induced bronchial inflammation and hyperreactivity.
    Lukacs NW; Glovsky MM; Ward PA
    Am J Physiol Lung Cell Mol Physiol; 2001 Mar; 280(3):L512-8. PubMed ID: 11159035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early inflammatory responses to Candida albicans infection in inbred and complement-deficient mice.
    Fulurija A; Ashman RB; Papadimitriou JM
    FEMS Immunol Med Microbiol; 1996 Jun; 14(2-3):83-94. PubMed ID: 8809543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Complement-endotoxin system interrelations. II. Role of the complement system and other effector systems in production of endotoxic shock].
    Negut EA
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1975; 20(1):1-14. PubMed ID: 128086
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of subcutaneous and intraperitoneal staphylococcal infections in normal and complement-deficient mice.
    Easmon CS; Glynn AA
    Infect Immun; 1976 Feb; 13(2):399-406. PubMed ID: 1262057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulatory properties of Nocardia lysozyme digest (NLD) in complement normal and C5-deficient mice.
    Georgieva P; Ivanovska N; Barot-Ciorbaru R
    Vaccine; 1998 Jul; 16(11-12):1237-42. PubMed ID: 9682384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Escherichia coli bacteremia in the squirrel monkey. I. Effect of cobra venom factor treatment.
    Gilbert DN; Barnett JA; Sanford JP
    J Clin Invest; 1973 Feb; 52(2):406-13. PubMed ID: 4630602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C5 deficiency in one atopic family.
    Borzini P; Mazzei D
    Boll Ist Sieroter Milan; 1977 Mar; 56(2):198-9. PubMed ID: 871347
    [No Abstract]   [Full Text] [Related]  

  • 38. Lincomycin protects mice from septic shock in beta-glucan-indomethacin model.
    Nameda S; Miura NN; Adachi Y; Ohno N
    Biol Pharm Bull; 2007 Dec; 30(12):2312-6. PubMed ID: 18057718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effect of glucan in experimentally induced candidiasis.
    Williams DL; Cook JA; Hoffmann EO; Di Luzio NR
    J Reticuloendothel Soc; 1978 Jun; 23(6):479-490. PubMed ID: 702473
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemoimmunotherapy of experimental hepatic metastases.
    Williams DL; Sherwood ER; McNamee RB; Jones EL; Browder IW; Di Luzio NR
    Hepatology; 1987; 7(6):1296-304. PubMed ID: 3315933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.